#IDO1
🚀Tools are here:
🦠Engineered Bifidobacterium consortia!
💊Dual IDO1/TDO inhibitors!
⌛Chrono-dosing strategies!
Together, they form synergistic “smart #Protocols” that adapt in real-time using “Saliva, #Plasma & “#Stool #Metabolomics! @mdpiopenaccess.bsky.social
👉 www.mdpi.com/2227-9059/13...
October 29, 2025 at 6:28 AM Everybody can reply
1 reposts 1 likes
🧬 Molecule of the Moment: #mRNA4359 + #pembrolizumab
At #ESMO2025, #Moderna reported early Phase 1/2 data showing mRNA-4359 may overcome checkpoint inhibitor–resistant #melanoma by targeting #PDL1 & #IDO1 pathways. Combo with pembrolizumab showed manageable safety, no new immune AEs.
October 22, 2025 at 6:20 AM Everybody can reply
Colon cancer reprograms tryptophan metabolism to augment VTE risk in mice, which is mitigated by an IDO1 inhibitor. Read in Blood Advances: buff.ly/SjLY4mI
October 17, 2025 at 12:44 PM Everybody can reply
journals.plos.org/plospathogen...

"study identifies IDO1 production as a key cell-autonomous defense mechanism that limits infection by C. burnetii, which suggests that peptides derived from hydrolysis of proteins in the CCV do not provide an adequate supply of tryptophan for bacterial replication"
Host cell depletion of tryptophan by IFNγ-induced Indoleamine 2,3-dioxygenase 1 (IDO1) inhibits lysosomal replication of Coxiella burnetii
Author summary Coxiella burnetii is a mammalian pathogen that can cause a predominantly zoonotic disease called Q-fever. In humans, Q-fever manifests as an acute or chronic illness especially in immun...
journals.plos.org
October 16, 2025 at 12:06 PM Everybody can reply
In @jem.org, Zhou et al. reveal that heterozygous JAK2V617F variant in megakaryocyte-erythroid progenitors drives essential #thrombocythemia via STAT1-IDO1-AhR-RUNX1, whereas the homozygous JAK2V617F variant promotes #polycythemia vera through the activation of STAT5. rupress.org/jem/article/...
October 15, 2025 at 6:30 PM Everybody can reply
Zhou et al. reveal that heterozygous JAK2V617F variant in megakaryocyte-erythroid progenitors drives essential #thrombocythemia via STAT1-IDO1-AhR-RUNX1, whereas the homozygous JAK2V617F variant promotes #polycythemia vera through the activation of STAT5. rupress.org/jem/article/...
October 15, 2025 at 5:00 PM Everybody can reply
1 likes
Immune Checkpoint Molecule Indoleamine 2,3-Dioxygenase 1 (IDO1) Is Expressed in Lymphoma Subtypes With and Without Epstein-Barr Virus
journals.lww.com/appliedimmun...
journals.lww.com
October 1, 2025 at 12:49 AM Everybody can reply
'(...) subpar responses following Francisella tularensis infection were associated with the inability of T cells to readily proliferate upon re-challenge (...) these features were partially a consequence of IFN-γ driven reprogramming of endothelial cells resulting in expression of IDO1'
#Immunology
Non-hematopoietic tryptophan metabolism is a driver of ineffective T cell responses during secondary pulmonary bacterial infection
Abstract. Pulmonary infections often fail to produce long-lived immune memory and the underlying mechanism(s) for this are unclear. Given the complex inter
academic.oup.com
September 16, 2025 at 3:44 PM Everybody can reply
Your brain's neurons aren't dying in Alzheimer's - they're STARVING 🧠
Stanford achieves COMPLETE memory restoration in AD models

Neurons aren't dying, they're starving due to IDO1 hijacking metabolism.

Block IDO1 = restored memory. Completely.

The drugs already exist.

youtube.com/shorts/jqVYd...
Memory COMPLETELY Restored in Alzheimer's Models
YouTube video by Dr. Kevin Tran
youtube.com
September 15, 2025 at 8:52 PM Everybody can reply
8/ Action steps TODAY:
✓ Get a sleep study (75% chance you need it)
✓ Monitor sleep quality religiously
✓ Watch for IDO1 inhibitor trials
✓ Don't wait for symptoms

Complete analysis: youtu.be/T5E2F92tYvU
Scientists Find New Way to Stop Memory Loss! APOE4 carriers pay attention!
YouTube video by Dr. Kevin Tran
youtu.be
September 12, 2025 at 5:26 PM Everybody can reply
6/ Here's the convergence:

IDO1 inhibitors? Already passed safety trials
CPAP for OSA? Protective against cognitive decline
DORAs? FDA-approved + reduce tau phosphorylation

The treatments EXIST
September 12, 2025 at 5:26 PM Everybody can reply
3/ When they blocked IDO1 in AD models:
✓ Complete restoration of spatial memory
✓ Normalized brain metabolism
✓ Worked for BOTH amyloid and tau
✓ Human AD cells showed same response

"Complete restoration to normal levels"
September 12, 2025 at 5:26 PM Everybody can reply
Dr. Andreasson discovered neurons aren't dying - they're STARVING

The IDO1 enzyme hijacks a critical metabolic switch, shutting down the brain's glucose-to-lactate conversion

Neurons lose their primary fuel source
September 12, 2025 at 5:26 PM Everybody can reply
1 likes
Pesquisadores da Universidade do Texas em Arlington identificaram duas enzimas, IDO1 e NOS, que afetam o metabolismo do colesterol durante a inflamação. Ao bloqueá-las, foi possível...

Matéria completa - regisandrade.com.br/cientistas-p...

#ciência #saúde #colesterol #descoberta #inovação #doenças
September 2, 2025 at 12:04 AM Everybody can reply
3 reposts 24 likes
New preprint reveals why IDO1 inhibitor trials failed! Led by Peter Murray @mpibiochem.bsky.social our collaboration discovered IDO1 actually kills ovarian cancer cells via GCN2/ISR pathway - not protecting them. Spatial proteomics uncovers unexpected biology.
www.biorxiv.org/content/10.1...
Spatial proteomics reveals mechanisms of cell-intrinsic tryptophan metabolism controlling ovarian cancer survival
Indole-2,3-dioxygenase (IDO1) depletes tryptophan to dampen anti‑tumor T cells, yet IDO1 inhibitors (IDO1i) have failed clinically. Using deep visual proteomics, we isolated IDO1 high, medium and low ...
www.biorxiv.org
August 20, 2025 at 5:15 AM Everybody can reply
6 reposts 18 likes 1 saves
University of Texas pinpointed a potential way to stop some of the deadliest modern diseases before they even start enzyme IDO1 that disrupts how immune cells called macrophages handle cholesterol during inflammation linked to heart disease, diabetes www.sciencedaily.com/releases/202...
August 16, 2025 at 11:48 AM Everybody can reply
Compelling Day 4 Plenary at #AAIC25 from Prof Katrin Andreasson of @stanfordpress.bsky.social showing "tremendous potential" for repurposing IDO1 inhibitors, trialled in cancer, for delaying progression in MCI and #AlzheimersDisease #dementiaresearch
July 30, 2025 at 6:23 PM Everybody can reply
1 likes